These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5536192)
1. The specificity hypothesis revisited. Weiner H Psychosom Med; 1970; 32(5):543. PubMed ID: 5536192 [No Abstract] [Full Text] [Related]
2. Paroxysmal arrhythmias in a case of diffuse toxic goiter. RAINONE S J Med Soc N J; 1951 Oct; 48(10):459-61. PubMed ID: 14874086 [No Abstract] [Full Text] [Related]
4. Hyperthyroidism. Bell GO Major Probl Clin Surg; 1974; 15(0):99-120. PubMed ID: 4609074 [No Abstract] [Full Text] [Related]
5. [Hyperthyroidism with cerebral embolies (author's transl)]. Merceron RE; Cavailloles F; Dairou R; Raymond JP; Cambier J; Klotz HP Ann Endocrinol (Paris); 1974; 35(3):267-8. PubMed ID: 4480449 [No Abstract] [Full Text] [Related]
6. Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy? Niepomniszcze H; Pitoia F; Goodall C; Manavela M; Bruno OD Thyroid; 2001 Oct; 11(10):991. PubMed ID: 11716050 [No Abstract] [Full Text] [Related]
7. Hyperthyroidism after thyroid suppression. Dunn JT Hosp Pract (Off Ed); 1982 Sep; 17(9):52-5. PubMed ID: 6809587 [No Abstract] [Full Text] [Related]
9. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)]. Diagne N; Faye A; Ndao AC; Djiba B; Kane BS; Ndongo S; Pouye A Pan Afr Med J; 2016; 25():6. PubMed ID: 28154699 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperthyroidism with radioiodine. WERNER SC NY Med; 1950 Jul; 6(14):13-5; passim. PubMed ID: 15439577 [No Abstract] [Full Text] [Related]
13. [Changes in the radioiodine uptake and uptake index after therapeutic treatment with I-131 radioiodine]. LENTI R Minerva Med; 1963 Feb; 54():399-403. PubMed ID: 13929654 [No Abstract] [Full Text] [Related]
14. [ON THE THERAPEUTIC EFFECTIVENESS OF I-131 IN VARIOUS FORMS OF THYROTOXICOSIS]. LIVERGANT Ie; CHEBOTAREVA ED; TARKHANOVA MV Med Radiol (Mosk); 1963 Jul; 8():29-34. PubMed ID: 14079831 [No Abstract] [Full Text] [Related]
15. [Thyrocalcitonin in euthyroid and toxic goiter]. Vasiukova EA; Zefirova GS; Kochergina II; Stekol'nikov LI; Briskin AI Sov Med; 1970 Dec; 33(12):3-6. PubMed ID: 5537682 [No Abstract] [Full Text] [Related]
16. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
17. [Thyroid hyperfunctioning states and disorders of cardiac rhythm]. Kulbertus H Rev Med Liege; 1973 Sep; 28(17):595-9. PubMed ID: 4127892 [No Abstract] [Full Text] [Related]
18. [OUR OWN RESULTS IN THE RADIOIODINE THERAPY OF HYPERTHYROIDISM]. HENNIG K Dtsch Gesundheitsw; 1965 May; 20():822-7. PubMed ID: 14306625 [No Abstract] [Full Text] [Related]
19. [Goiters in the newborn]. Job JC; Bocquentin F; Canlorbe P Arch Fr Pediatr; 1974; 31(2):127-36. PubMed ID: 4136368 [No Abstract] [Full Text] [Related]
20. [ON FRACTIONAL RADIOIODINE TREATMENT OF THYROTOXICOSIS]. FRIDRICH R; WALSER A Schweiz Med Wochenschr; 1965 Mar; 95():413-6. PubMed ID: 14277008 [No Abstract] [Full Text] [Related] [Next] [New Search]